Bibliography

Found 1068 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Lee D, Levine AJ, Ando K, Singer EJ. Comparing the accuracy of neuropsychological testing methods in determining neurocognitive impairment in HIV-infected Spanish speaking adults. In: UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. Los Angeles, CA; 2010.
Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Lopez E, Mathisen G, Donovan S, Singer EJ. A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehav HIV Med. 2011 ;3:79-86.
Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Singer EJ. A comparison of three screening tests for detecting HIV-associated neurocognitive disorder in Latin America Spanish Speakers. 2011 .
McGuire JL, Gill AJ, Douglas SD, Kolson DL. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth. J Neurovirol. 2016 ;22(6):823-830.
Marquine MJ, Flores I, Kamat R, Johnson N, Umlauf A, Letendre S, Jeste D, Grant I, Moore D, Heaton RK. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neurovirol. 2018 ;24(5):549-556.
Sakharkar MK, Chow VTK, Ghosh K, Chaturvedi I, Lee PC, Bagavathi SP, Shapshak P, Subbiah S, Kangueane P. Computational prediction of SEG (single exon gene) function in humans. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2005 ;10:1382-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15769633
Gonzalez RG, Heaton RK, Moore D, Letendre S, Ellis RJ, Wolfson TJ, Marcotte TD, Cherner M, Rippeth JD, Grant I, et al. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359
Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. Journal of Acquired Immune Deficiency Syndromes . 2019 ;81.
Levine AJ, Singer EJ, Bilder R, Shapshak P, Sinsheimer JS. COMT val168met polymorphism confers risk for working memory impairment in HIV. In: Third Meeting on HIV Infection and the Central Nervous System. Third Meeting on HIV Infection and the Central Nervous System. Stresa, Italy; 2009.
Marcotte TD, Deutsch R, Michael BDaniel, Franklin D, Cookson DRosario, Bharti AR, Grant I, Letendre S. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.
Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.
Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Kohli M, Fisher A, Sun-Suslow N, Heaton A, Dawson MS, Marquie J, Franklin DR, Marquine M, Iudicello JE, Heaton RK, et al. Concurrent validity and reliability of at-home teleneuropsychological evaluations among people with and without HIV. J Int Neuropsychol Soc. 2023 ;29(2):193-204.
Malik S, Theis M, Eugenin EA. Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV. Front Mol Neurosci. 2017 ;10:404.
Musich T, Peters PJ, Duenas-Decamp MJosé, Gonzalez-Perez M, Robinson J, Zolla-Pazner S, Ball JK, Luzuriaga K, Clapham PR. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol. 2011 ;85(5):2397-405.
Woods SPaul, Scott JC, Dawson MS, Morgan EE, Carey C, Heaton RK, Grant I. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2005 ;20(8):1061-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16198529
Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010 ;67(5):552-8.
Langford D, Baron D, Joy J, Del-Valle L, Shack J. Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation. Psychoneuroendocrinology [Internet]. 2011 ;36:710-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21115295
Micheletti RG. Coronary Artery Disease in HIV-Infected Patients. In: Duke University School of Medicine Alpha Omega Alpha Day. Duke University School of Medicine Alpha Omega Alpha Day. Durham, NC; 2007.
Micheletti RG. Coronary Atherosclerosis in HIV-Infected Patients. In: 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Sydney, Australia; 2007.
Micheletti RG, Fishbein GA, Fishbein MC, Singer EJ, Weiss RE, Jeffries RA, Currier JS. Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovascular Pathology [Internet]. 2008 ;18:28-36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18402832
Morgello S. Coronaviruses and the central nervous system. J Neurovirol. 2020 ;26(4):459-473.
Levine AJ, Soontornniyomkij V, Masliah E, Sinsheimer JS, Ji SS, Horvath S, Singer EJ, Kallianpur A, Moore DJ. Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders. J Neurovirol. 2020 ;26(4):509-510.
Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.
Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I, Mallory ME, Miller A, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology [Internet]. 2004 ;61(3):369-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15023814

Pages